Genetic screening for SPINK1 (serine peptidase inhibitor, Kazal type 1), PRSS1 (cationic trypsinogen gene) and CFTR (cystic fibrosis transmembrane conductance regulator) gene mutations was performed for 12 of 30 cases with recurrent AP (40%). This evidence concerns the gene PRSS1 and alkaline phosphatase measurement.